Immune Checkpoint Inhibitor Therapy for Cancer
Understanding immunE-related toXicities by multifACeT Profiling
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Other
This trial is looking for adults with a diagnosis of solid cancer who are about to start immune checkpoint inhibitor therapy. Participants will help researchers understand the side effects of this treatment.
You may be able to join if
- I am 18 years or older
- I have been diagnosed with a solid cancer
- I have a treatment plan to start immune checkpoint inhibitor therapy
- I have given written informed consent
You may not be able to join if
- I have a medical or psychological condition that prevents me from giving informed consent
- I am planned to participate in another drug trial
- I have already started immune checkpoint inhibitor therapy before joining this study
- I am unable to follow the study or sample schedule
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityA prospective observational cohort study of patients undergoing CPI therapy in which translational research is the fundamental aspect of the study.
Loading trial locations…